CST3 and kidney disorder: Currently, Kidney Disease Improving Global Outcomes (KDIGO) recommends the use of cystatin C-based equations whenever eGFR calculated with creatinine-based equations is 45–60 mL/min (borderline normality) in the absence of other evidence of kidney damage6.